Abstract
Drug adherence of patients with epilepsy was investigated to determine the reasons behind poor adherence. In this retrospective chart review study, all patients with a clinical diagnosis of epilepsy were recruited at the outpatient epilepsy clinic at Shiraz University of Medical Sciences. We routinely asked about the patient’s drug adherence and reasons behind poor drug adherence in every office visit. We defined drug adherence adequate if the patient reported less than or equal to one missed dose per month. Patients’ drug adherences were investigated during two time periods: March 2010–2011 (before intensification of the international economic sanctions against Iran), and September 2012–2013 (during intensified international economic sanctions). One hundred and ninety-nine patients were studied. Drug adherence was satisfactory in 139 patients (69.8 %) during the first time period. Drug adherence was satisfactory in 146 patients (73.4 %) during the second time period. The most common reasons for poor drug adherence was carelessness, followed by cost and lack of drug availability (1.5 % in the first time period and 4 % in the second time period; P = 0.07). About one-third of patients with epilepsy had poor drug adherence. To overcome the problem, it is important to find the reasons behind poor drug adherence in each patient and try to overcome the cause. Purely from a clinical and patient care perspective, it seems necessary that politicians should facilitate decisions that make the health and well-being of ordinary people more affordable and without hardship.
Similar content being viewed by others
References
Blackwell B (2000) Treatment compliance. In: Kaplan and Sadock’s comprehensive textbook of psychiatry, 7th edn, vol. 2. Lippincott Williams and Wilkins, Philadelphia, pp 1893–1898
Kyngas H (2000) Compliance with health regimens of adolescents with epilepsy. Seizure 9(5):598–604
Asadi-Pooya AA (2005) Drug compliance of children and adolescents with epilepsy. Seizure 14(6):393–395
Asadi-Pooya AA, Emami M, Ashjazadeh N et al (2013) Reasons for uncontrolled seizures in adults; the impact of pseudointractability. Seizure 22(4):271–274
Lie IA, Hoggen I, Samsonsen C, Brodtkorb E (2015) Treatment non-adherence as a trigger for status epilepticus: an observational, retrospective study based on therapeutic drug monitoring. Epilepsy Res 113:28–33
Faught E (2012) Adherence to antiepilepsy drug therapy. Epilepsy Behav 25:297–302
Peterson GM, McLean S, Millingen KS (1982) Determinants of patient compliance with anticonvulsant therapy. Epilepsia 23(6):607–613
Brown I, Sheeran P, Reuber M (2009) Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy Behav 16(4):634–639
Tang F, Zhu G, Jiao Z, Ma C, Wang B (2013) Self-reported adherence in patients with epilepsy who missed their medications and reasons for nonadherence in China. Epilepsy Behav 27(1):85–89
Liu L, Yiu CH, Yen DJ, Chou MH, Lin MF (2003) Medication education for patients with epilepsy in Taiwan. Seizure 12(7):473–477
Koshy S (2012) Role of pharmacists in the management of patients with epilepsy. Int J Pharm Pract 20(1):65–68
Law MR, Cheng L, Dhalla IA, Heard D, Morgan SG (2012) The effect of cost on adherence to prescription medications in Canada. CMAJ 184(3):297–302
Sweileh WM, Ihbesheh MS, Jarar IS et al (2011) Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 21(3):301–305
Acknowledgments
This work was supported by the Neurosciences Research Center, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran [Grant number 93-01-55-7704].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was conducted with the approval by Shiraz University of Medical Sciences Institutional Review Board.
Informed consent
This was a retrospective chart review study and no written consent was needed. However, the patients routinely consent orally at the first visit that their information will be used anonymously in the future studies, like this one, at our clinic; if they do not agree, their charts will not be used in studies.
Additional information
All the authors have similar contributions to the paper.
Rights and permissions
About this article
Cite this article
Asadi-Pooya, A.A., Tavana, B., Tavana, B. et al. Drug adherence of patients with epilepsy in Iran: the effects of the international economic sanctions. Acta Neurol Belg 116, 151–155 (2016). https://doi.org/10.1007/s13760-015-0545-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-015-0545-6